Dedicated to advancing neurointerventional therapies for stroke

ABOUT NEURAVI Led by a team experienced in endovascular device development and global commercialization, the company’s initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks to develop new understanding that will drive innovative solutions to treat this challenging and devastating disease.

Thromboembolic Research Commitment

Thromboembolic
Research Commitment

Interdisciplinary collaboration to further understanding of thromboembolic mechanics


Learn more →

Neuravi Solution

Neuravi Solution

The EmboTrap® Revascularization Device is a new minimally invasive platform for treating acute ischemic stroke

Learn more →

Clinical Studies

Clinical Studies

Neuravi is committed to developing clinical data to advance the treatment
of stroke
 

Learn more →

Experienced  Leadership Team

Experienced
Leadership Team

Accomplished in bringing breakthrough medical device technologies to market
 

Learn more →

Not yet available for sale or clinical use in the USA.